Aurobindo Pharma Limited — Others, 11-11-2024: Copy of Newspaper Publication

Aurobindo Pharma Limited reported its unaudited financial results for the second quarter and half year ending September 30, 2024. Total income from operations was ₹77,960.7 million, with a net profit after tax of ₹8,169.5 million. Earnings per share for the quarter was ₹14.00, reflecting strong performance compared to the previous year. The results highlight the company's ongoing growth trajectory in the pharmaceutical sector. Detailed results are available on stock exchange websites and the company’s website.